FDA recall D-1489-2019

Fresenius Kabi USA, LLC · Class I · drug

Product

Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi, Lake Zurich, IL 60047. 63323-117-61 [Fresenius Kabi brand] and NDC 63323-117-69 [NOVAPLUS brand]

Reason for recall

Presence of Particulate Matter; glass particulates

Distribution

Nationwide USA and Puerto Rico

Key facts

Status
Terminated
Initiation date
2019-06-28
Report date
2019-07-24
Termination date
2022-09-20
Voluntary/Mandated
Voluntary: Firm initiated
Location
Melrose Park, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1489-2019